Delivery Order SPE2DB20D1109-SPE2DB25FP74D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,505.19 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract is non-set-aside and was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,103.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,015.55 delivery order to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 20 MEQ tablets (100-count packaging) under a firm fixed price contract. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,639.37 on August 14, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500. This firm fixed-price, competitively awarded contract is scheduled for ultimate completion on August 15, 2025, with performance conducted at the vendor's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $47,517.99, represents a non-competitive, non-set-aside award with an ultimate completion date of September 9, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,143.33 delivery order to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 18, 2025. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP74DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,137.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ. This is a firm fixed-price, competitively awarded contract with a completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated extensive capability in fulfilling federal medical procurement requirements through its substantial portfolio of federal contract awards covering a wide spectrum of medications and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/11/25 |